Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Scribd Logo
Upload

Welcome to Scribd!

  • 119 views

    Treatment

    Uploaded by

    api-282091976
    There are currently seven FDA-approved drugs to treat chronic hepatitis B virus (HBV) infection that can slow liver damage by decreasing viral reproduction. While these treatments do not provide a complete cure, they significantly reduce the risk of progressive liver disease. Not all HBV patients require treatment, and patients should discuss options with their doctor. Many clinical trials are investigating new treatments that may offer patients the opportunity to benefit from advances in HBV research.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    Treatment

    Uploaded by

    api-282091976
    119 views1 page
    There are currently seven FDA-approved drugs to treat chronic hepatitis B virus (HBV) infection that can slow liver damage by decreasing viral reproduction. While these treatments do not provide a complete cure, they significantly reduce the risk of progressive liver disease. Not all HBV patients require treatment, and patients should discuss options with their doctor. Many clinical trials are investigating new treatments that may offer patients the opportunity to benefit from advances in HBV research.

    Original Title

    treatment

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    There are currently seven FDA-approved drugs to treat chronic hepatitis B virus (HBV) infection that can slow liver damage by decreasing viral reproduction. While these treatments do not provide a complete cure, they significantly reduce the risk of progressive liver disease. Not all HBV patients require treatment, and patients should discuss options with their doctor. Many clinical trials are investigating new treatments that may offer patients the opportunity to benefit from advances in HBV research.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    119 views1 page

    Treatment

    Uploaded by

    api-282091976
    There are currently seven FDA-approved drugs to treat chronic hepatitis B virus (HBV) infection that can slow liver damage by decreasing viral reproduction. While these treatments do not provide a complete cure, they significantly reduce the risk of progressive liver disease. Not all HBV patients require treatment, and patients should discuss options with their doctor. Many clinical trials are investigating new treatments that may offer patients the opportunity to benefit from advances in HBV research.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    You are on page 1of 1

    Hepatitis B Foundation

    Cause for a Cure

    www.hepb.org

    Hepatitis B Treatment Information


    The future looks bright for those who are chronically infected with the hepatitis B virus (HBV).
    Only 10 years ago, there were no options. Now, there are promising drugs that can slow down liver damage caused by the virus. This means that there will be less damage done to the liver, and less chance of
    developing serious liver disease later on. With all of the exciting new research, there is great hope that a
    complete cure is on the horizon for people living with chronic hepatitis B!
    What treatments are currently approved for HBV? The good news is that there are several promising treatment options. Currently, there are seven FDA approved drugs in the U.S. to
    treat chronic HBV: Intron A (Interferon Alpha), Pegasys (Pegylated Interferon), Epivir HBV
    (Lamivudine), Hepsera (Adefovir), Baraclude (Entecavir), Tyzeka (Telbivudine), and Viread
    (Tenofovir).
    You and your doctor will need to discuss the treatment options before deciding which one is best for you.
    For many patients, these medications will decrease or stop hepatitis B virus reproduction. This results in
    patients feeling better within a month or two because liver damage from the virus iis slowed down, or even
    reversed in some cases. Although the FDA has approved these drugs for chronic hepatitis B, they do not
    provide a complete cure at this time. They do, however, significantly decrease the risk of progressive liver
    damage from the hepatitis B virus. To learn more about these approved drugs as well as the experimental
    drugs still being tested, visit the Hepatitis B Foundations HBV Drug Watch at www.hepb.org.
    Does every patient need to be treated? It is important to know that not every patient with chronic HBV
    needs to be on medication. Patients with active signs of liver disease may benefit the most from treatment. However, all chronically infected patients should be seen by their doctor at least once a year (or
    more frequently) for regular medical follow-up care, whether they start treatment or not. Talk to
    your doctor about approved treatments or whether there are any clinical trials of new HBV
    drugs that you might be eligible for and could benefit from.
    What about clinical trials? Clinical trials are carefully controlled studies that are used to determine whether new drugs, treatments, or medical products are safe and effective. People volunteer to
    participate in these trials as they can provide patients the opportunity to potentially benefit from the latest
    advances in medical science. There are many HBV treatments that are currently in clinical trial, and many
    new and promising treatments on the horizon. To help you learn more, the Hepatitis B Foundation
    maintains a list of hepatitis B clinical trials on its website at www.hepb.org/patients/hepatitis_b_clinical_trials.
    How can I learn more about treatment for HBV? First, talk to your doctor. If he or she is unfamiliar
    with the latest treatment advances, contact a liver specialist (hepatologist). Be sure to visit
    the Hepatitis B Foundation website at www.hepb.org for a national directory of liver specialists,
    an updated Drug Watch, and HBV clinical trial sites. Call us at 215-489-4900 or email us at
    info@hepb.org for more personalized information and referrals. You can also visit the National
    Institutes of Health (NIH) clinical trials site at www.clinicaltrials.gov or Center Watch at
    www.centerwatch.com.

    Hepatitis B Foundation 3805 Old Easton Road, Doylestown PA 18902 215-489-4900 info@hepb.org

    You might also like